Seroconversion following the first, second, and third dose of SARS-CoV-2 vaccines in immunocompromised population: a systematic review and meta-analysis

BACKGROUND: Immunocompromised (IC) patients are at higher risk of more severe COVID-19 infections than the general population. Special considerations should be dedicated to such patients. We aimed to investigate the efficacy of COVID-19 vaccines based on the vaccine type and etiology as well as the...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehrabi Nejad, Mohammad-Mehdi, Shobeiri, Parnian, Dehghanbanadaki, Hojat, Tabary, Mohammadreza, Aryannejad, Armin, Haji Ghadery, Abdolkarim, Shabani, Mahya, Moosaie, Fatemeh, SeyedAlinaghi, SeyedAhmad, Rezaei, Nima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358061/
https://www.ncbi.nlm.nih.gov/pubmed/35941646
http://dx.doi.org/10.1186/s12985-022-01858-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358061/
https://www.ncbi.nlm.nih.gov/pubmed/35941646
http://dx.doi.org/10.1186/s12985-022-01858-3

Ejemplares similares